Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.
about
Cancer-Associated Myeloid Regulatory CellsSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyThe Nature of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentThe innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells.A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice.Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity.Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancerA core of kinase-regulated interactomes defines the neoplastic MDSC lineage.Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursDynamics of the spleen and its significance in a murine H22 orthotopic hepatoma model.Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs.Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection.The roles of myeloid-derived suppressor cells in transplantation.Drafting the proteome landscape of myeloid-derived suppressor cells.Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.Change in CD3ζ-chain expression is an independent predictor of disease status in head and neck cancer patients.TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function.Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy.Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells.Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer TherapyTurn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
P2860
Q26750382-65D6F969-3F25-45F9-92FC-FC0DAC1B6491Q28080262-67FF0030-03B2-49A3-BFF8-6CA63FB0F56EQ28388630-BCC8EEEF-C311-4534-AF22-C3CBDB2FE94DQ33660069-45AE8A55-F063-4C07-A9C3-ED460A067C08Q34334399-E52306D6-F452-472F-9304-BFAF37AF674DQ34365909-13778004-D29B-4A95-887C-0334A3B82616Q34654430-A26DF4EB-5A9B-423C-8B8E-E85920237DB7Q35798966-5A4B82F8-EB58-4B90-8C06-9DA58AA94272Q35828574-8DD1C708-09BC-4A61-8208-77DCE1EB8E92Q36413721-F593A1BB-798A-4EAE-9341-FA0D72C0DDA5Q36597506-DD437B8A-9D15-434E-BDA1-4188951A0381Q36638606-A2A8AD8B-0673-4D6F-996C-948396BC2526Q37107253-F90D2855-1BF3-4957-9B32-B2E5F5D32423Q37447879-01B632C2-CFE7-4F97-BEDB-0CC1B9123DB4Q37732211-FB31EED3-D05B-483F-A456-BB47270CB752Q38239562-6E031C9A-B66D-4ED6-8028-D7C0BBC6631EQ38592376-BC95A437-5799-4545-98DF-97CB59C3E4ABQ38993068-84BD296C-8CD0-407B-B750-ED564AB1EECEQ40903579-64C82EB0-4E93-4C91-9650-6BBC96E0E4BBQ41968526-7EDB6F17-EF98-455C-85BF-33D8E6056BB3Q42124738-C2C1B4E9-DC24-4360-9FF1-32FC156AF565Q42840029-98F415D3-18E6-45FD-938F-6587092B3062Q57817490-C254A3E7-9F7E-471A-B621-1EAD78B7BCC9Q58780996-8FA0451C-2038-41F6-BC7C-2323699F77F8
P2860
Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Enhanced suppressive capacity ...... their peripheral counterparts.
@en
Enhanced suppressive capacity ...... their peripheral counterparts.
@nl
type
label
Enhanced suppressive capacity ...... their peripheral counterparts.
@en
Enhanced suppressive capacity ...... their peripheral counterparts.
@nl
prefLabel
Enhanced suppressive capacity ...... their peripheral counterparts.
@en
Enhanced suppressive capacity ...... their peripheral counterparts.
@nl
P2093
P2860
P356
P1476
Enhanced suppressive capacity ...... their peripheral counterparts.
@en
P2093
Joeri L Aerts
Kris Thielemans
Perpetua U Emeagi
Sandra Van Lint
Sarah K Maenhout
P2860
P304
P356
10.1002/IJC.28449
P577
2013-09-23T00:00:00Z